cam a22 4 4500 390168033 CHVBK 20201005113245.0 161201s2015 xxu 00 eng|d GBB5-97093 bnb 978-0-226-04971-7 hbk. (IDSBB)006412257 (IDSLU)001225561 (NEBIS)010864474 (VAUD)991005802029702852 (RNV)008449342-41bculausa_network (RERO)008449342 R008449342 (EXLNZ-41BCULAUSA_NETWORK)991020256099702851 StDuBDS SzZuIDS BS/BE B452 kids R151 .A76 2015 2015 J-601 WA 11 AA1 s1me rero 610 15 610.289 23 Aronowitz Robert A. Risky medicine our quest to cure fear and uncertainty Robert Aronowitz Chicago The University of Chicago Press 2015 278 Seiten Includes bibliographical references and index Risky medicine : our quest to cure fear and uncertainty -- The converged experience of risk and disease -- The social and psychological efficacy of risk interventions -- The Framingham heart study and the emergence of the risk factor approach to coronary heart disease : 1947-1970 -- Gardasil : a vaccine against cancer and a drug to reduce risk -- The rise and fall of the lyme disease vaccines : a cautionary tale for risk interventions in American medicine and public health -- Cancer survivorship : the entangled experience of risk and disease -- The global circulation of risk interventions -- Situating health risks : an opportunity for disease prevention policy -- Epilogue : the risk system Will ever-more sensitive screening tests for cancer lead to longer, better lives? Will anticipating and trying to prevent the future complications of chronic disease lead to better health? Not always, says Robert Aronowitz in Risky Medicine. In fact, it often is hurting us. Exploring the transformation of health care over the last several decades that has led doctors to become more attentive to treating risk than treating symptoms or curing disease, Aronowitz shows how many aspects of the health system and clinical practice are now aimed at risk reduction and risk control. He argues that this transformation has been driven in part by the pharmaceutical industry, which benefits by promoting its products to the larger percentage of the population at risk for a particular illness, rather than the smaller percentage who are actually affected by it. Meanwhile, for those suffering from chronic illness, the experience of risk and disease has been conflated by medical practitioners who focus on anticipatory treatment as much if not more than on relieving suffering caused by disease. Drawing on such controversial examples as HPV vaccines, cancer screening programs, and the cancer survivorship movement, Aronowitz argues that patients and their doctors have come to believe, perilously, that far too many medical interventions are worthwhile because they promise to control our fears and reduce uncertainty. Gesundheitswesen (DE-588)4020775-4 gnd Risikofaktor (DE-588)4050131-0 gnd Preventive Medicine (DNLM)D011315 Disease (DNLM)D004194 Medicine, Preventive United States History 20th century Diseases Risk factors Social aspects United States Medical care United States History 20th century Preventive Medicine history History, 20th Century Risk Assessment Risk Factors United States u MS 6200 idslu LR BK020000 XK020000 XK020000 UFBI-201806 nebis EN me SzZuIDS BS/BE 140 IDS LU UMBCMEDGES UMBC-201806 VAUD iuhm iuhm HMA 25225 DMb 810820001 NEBIS UMBC UMBC ULCAR WA 11-50 IDSLU LUUHL LUUHL UHFRE MS 6200 2015 IDSBB B452 B452 452LB MED_WA_108 12 NELB4521510 IDSBB 100 1- Aronowitz Robert A. IDSLU 100 1- Aronowitz Robert Alan 1953- (DE-588)131663410 Verfasser aut NEBIS 100 1- Aronowitz Robert Alan 1953- (DE-588)131663410 Verfasser aut VAUD 100 1- Aronowitz Robert A. aut NEBIS UZH50 EBI01 UMBC https://opac.nebis.ch/objects/pdf03/UMBC_978-0-226-04971-7_01.pdf Titelblatt und Inhaltsverzeichnis VIEW pdf IDSLU ILU50 ILU01 LUZHB https://www.ub.unibas.ch/tox/HBZ/HT018717638/PDF pdf VIEW Inhaltsverzeichnis